Skip to main content

Invesco Ltd.

SEC CIK
0000914208
Latest filing
Aug 14, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by Invesco Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
4,234,231
Value
$1.64B
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ELV by Invesco Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,234,231$1.64B0.1%−583,179−12.1%ReducedHolders
Q1 20264,817,410$1.41B0.1%+913,532+23.4%AddedHolders
Q4 20253,903,878$1.37B0.1%+1,306,390+50.3%AddedHolders
Q3 20252,597,488$839.3M0.1%+484,303+22.9%AddedHolders
Q2 20252,113,185$821.9M0.1%−3,104−0.1%ReducedHolders
Q1 20252,116,289$920.5M0.2%+24,833+1.2%AddedHolders
Q4 20242,091,456$771.5M0.1%−290,352−12.2%ReducedHolders
Q3 20242,381,808$1.24B0.2%+551,585+30.1%AddedHolders
Q2 20241,830,223$991.7M0.2%−207,037−10.2%ReducedHolders
Q1 20242,037,260$1.06B0.2%+101,406+5.2%AddedHolders
Q4 20231,935,854$912.9M0.2%+80,324+4.3%AddedHolders
Q3 20231,855,530$807.9M0.2%+54,877+3.0%AddedHolders
Q2 20231,800,653$800.0M0.2%−189,335−9.5%ReducedHolders
Q1 20231,989,988$915.0M0.3%−411,268−17.1%ReducedHolders
Q4 20222,401,256$1.23B0.4%−422,994−15.0%ReducedHolders
Q3 20222,824,250$1.28B0.4%−236,578−7.7%ReducedHolders
Q2 20223,060,828$1.48B0.4%+100,655+3.4%AddedHolders
Q1 20222,960,173$1.45B0.4%+28,289+1.0%AddedHolders
Q4 20212,931,884$1.36B0.3%−23,426−0.8%ReducedHolders
Q3 20212,955,310$1.10B0.3%+671,275+29.4%AddedHolders
Q2 20212,284,035$872.0M0.2%−162,937−6.7%ReducedHolders
Q1 20212,446,972$878.3M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.